|
cell aggregation
|
GO_0098743 |
[The clustering together and adhesion of initially separate cells to form an aggregate. Examples include the clustering of unicellular organisms or blood cells in suspension and the condensation of mesenchymal cells during cartilage formation.] |
|
histamine secretion
|
GO_0001821 |
[The regulated release of histamine by a cell or tissue. It is formed by decarboxylation of histidine and it acts through receptors in smooth muscle and in secretory systems.] |
|
secretion
|
GO_0046903 |
[The controlled release of a substance by a cell or a tissue.] |
|
histamine transport
|
GO_0051608 |
[The directed movement of histamine into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Histamine is a physiologically active amine, found in plant and animal tissue and released from mast cells as part of an allergic reaction in humans.] |
|
1-phosphatidylinositol 4-kinase activator activity
|
GO_0098744 |
[Binds to and increases the activity of 1-phosphatidylinositol 4-kinase.] |
|
RNA decapping complex
|
GO_0098745 |
[A protein complex consisting of a Dcp1 regulatory subunit and a Dcp2 catalytic subunit that has mRNA cap binding activity and is involved in decapping of nuclear-transcribed mRNA.] |
|
fast, calcium ion-dependent exocytosis of neurotransmitter
|
GO_0098746 |
[The fast, initial phase of calcium ion-induced neurotransmitter release, via exocytosis, into the synaptic cleft. This depends on low affinity calcium sensors and typically begins a fraction of a millisecond after Ca2+ influx, and decays rapidly (1-10ms) with a decay constant of around 5-10ms. The underlying molecular mechanisms of this process are distinct from those of the later, slow phase of release.] |
|
slow, calcium ion-dependent exocytosis of neurotransmitter
|
GO_0098747 |
[The slow, second phase of calcium ion-induced neurotransmitter release, via exocytosis, into the synaptic cleft. This depends on high affinity calcium sensors and decays slowly, typically with a decay constant of over 100ms. The underlying molecular mechanisms of this process are distinct from those of the earlier, fast phase of release.] |
|
GO_0098748
|
GO_0098748 |
|
|
cerebellar neuron development
|
GO_0098749 |
[The process whose specific outcome is the progression of a cerebellar neuron over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell.] |
|
vestibular receptor cell stereocilium organization
|
GO_0060121 |
[A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a stereocilium. A stereocilium is an actin-based protrusion from the apical surface of vestibular hair cells.] |
|
negative regulation of fusion cell fate specification
|
GO_0035157 |
[Any process that restricts, stops or prevents a cell from adopting a fusion cell fate. Once the terminal and fusion fates have been correctly induced, inhibitory feedback loops prevent the remaining branch cells from assuming similar fates.] |
|
embryonic process involved in female pregnancy
|
GO_0060136 |
[A reproductive process occurring in the embryo or fetus that allows the embryo or fetus to develop within the mother.] |
|
regulation of tube diameter, open tracheal system
|
GO_0035158 |
[Ensuring that a tube in an open tracheal system is of the correct diameter. When primary branches form their lumens are small (less than 2 micrometers) in caliber and must undergo regulated expansion during larval life to reach their mature size.] |
|
regulation of tube size, open tracheal system
|
GO_0035151 |
[Ensuring that an epithelial tube in an open tracheal system is of the correct length and diameter. Tracheal tubes undergo highly regulated tube-size increases during development, expanding up to 40 times their initial size by the end of larval life. Tube size appears to be controlled by regulation of apical membrane expansion and secretion, rather than by changes in cell number, size or shape.] |
|
somatotropin secreting cell development
|
GO_0060133 |
[The process whose specific outcome is the progression of a somatotropin secreting cell over time, from its formation to the mature structure. A somatotropin secreting cell is an acidophilic cell of the anterior pituitary that produces growth hormone, somatotropin.] |
|
negative regulation of terminal cell fate specification, open tracheal system
|
GO_0035155 |
[Any process that restricts, stops or prevents a cell from adopting a terminal cell fate in an open tracheal system. Once the terminal and fusion fates have been correctly induced, inhibitory feedback loops prevent the remaining branch cells from assuming similar fates.] |
|
prepulse inhibition
|
GO_0060134 |
[The process in which a startle magnitude is reduced when the startling stimulus is preceded by a low-intensity prepulse.] |
|
fusion cell fate specification
|
GO_0035156 |
[The process in which a cell becomes capable of differentiating autonomously into a fusion cell in an environment that is neutral with respect to the developmental pathway; upon specification, the cell fate can be reversed. Fusion cells allow the interconnection of adjacent tracheal metameres during tracheal tube fusion.] |
|
epithelial cell type specification, open tracheal system
|
GO_0035153 |
[Allocation of epithelial cells within each migrating branch in an open tracheal system to distinct tracheal cell fates. During the migration phase each branch forms a well-defined number of cell types (including fusion cells, terminal cells and branch cells) at precise positions.] |